Entities / Company
Novocure (Jersey).
company in Saint Helier, Jersey
- Reports this week
- 0
- Active events
- 0
- Connections
- 34
What's happening
Gone quiet
No new reports in 90+ days-
Novocure established its global headquarters in Baar, Switzerland, and maintains research and development facilities in Haifa, Israel. The company also uses LinkedIn and Twitter for updates.Some support3 reports
-
Novocure's stock price was boosted by strong market conditions on June 30, 2025.Speculative1 report
-
Leerink partners reiterated a Buy rating on Novocure Limited, citing solid results regarding its Optune/TTFields therapy.Some support2 reports
-
Novocure submitted a PMA application for its proprietary TTFields therapy, Optune Lua, targeting pancreatic cancer.Some support2 reports
-
Novocure announced coverage in Spain, appointing a country manager and gaining availability through the Spanish Ministry of Health.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Novocure (Jersey) this week
News at the entities that move Novocure (Jersey) most-
FDA StructuralCongress and the Senate are considering legislation affecting FDA submissions and drug patent rights.Moves Novocure (Jersey)
-
Switzerland Shared contextIran institutes a militia system modeled after Switzerland and sanctions are lifted, enabling trade and relations.Moves Novocure (Jersey)
-
Haifa Shared contextHaifa council is reviewing its twinning agreement with Hackney amid current geopolitical crises.Moves Novocure (Jersey)
-
Twitter Mentioned togetherLee Jae Myung used Twitter for direct public communication on October 19, 2026.Moves Novocure (Jersey)
-
LinkedIn Mentioned togetherA dispute arose over false and defamatory advertisements involving a son's LinkedIn profile, operating under Pennsylvania state law.Moves Novocure (Jersey)
Connections
The 6 strongest of 34, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Novocure submits therapeutic applications to the FDA for regulatory review and approval.
-
MPM Transactional
MPM generated $0.8 million in revenue from Optune Lua, a product related to Novocure, for treating malignant pleural mesothelioma.
-
LinkedIn Mentioned together
Novocure follows LinkedIn's professional profile on the platform.
-
Twitter Mentioned together
Novocure follows Twitter's account on social media.
-
Switzerland Shared context
Novocure's global headquarters is located in Switzerland.
-
Haifa Shared context
Novocure maintains research and development facilities located in Haifa.
History
Events by the month they beganJune 2026
5 events- Novocure established its global headquarters in Baar, Switzerland, and maintains research and development facilities in Haifa, Israel. The company also uses LinkedIn and Twitter for updates.
- Novocure's stock price was boosted by strong market conditions on June 30, 2025.
- Leerink partners reiterated a Buy rating on Novocure Limited, citing solid results regarding its Optune/TTFields therapy.
- Novocure submitted a PMA application for its proprietary TTFields therapy, Optune Lua, targeting pancreatic cancer.
- Novocure announced coverage in Spain, appointing a country manager and gaining availability through the Spanish Ministry of Health.